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Abstract 
The major platform for high level recombinant protein production is based on genetically modified microorgan‑
isms like Escherichia coli (E. coli) due to its short dividing time, ability to use inexpensive substrates and additionally, 
its genetics is comparatively simple, well characterized and can be manipulated easily. Here, we investigated the 
possibilities of finding the best media for high cell density fermentation, by analyzing different media samples, focus‑
ing on improving fermentation techniques and recombinant protein production. Initial fermentation of E. coli BL21 
DE3:pAV01 in baffled flasks showed that high cell density was achieved when using complex media, Luria–Bertani (LB) 
and Terrific medium broth (TB) (10 and 14 g/L wet weight, respectively), as compared to mineral media M9, modified 
minimal medium (MMM) and Riesenberg mineral medium (RM) (7, 8 and 7 g/L, respectively). However, in fed‑batch 
fermentation processes when using MMM after 25 h cultivation, it was possible to yield an optical density (OD600) 
of 139 corresponding to 172 g/L of wet biomass was produced in a 30 L TV Techfors‑S Infors HT fermenter, with a 
computer controlled nutrient supply (glucose as a carbon source) delivery system, indicating nearly 1.5 times that 
obtained from TB. Upon purification, a total of 1.65 mg/g of protein per gram cell biomass was obtained and the puri‑
fied AviPure showed affinity for immunoglobulin. High cell density fed batch fermentation was achieved by selecting 
the best media and growth conditions, by utilizing a number of fermentation parameters like media, fermentation 
conditions, chemical concentrations, pO2 level, stirrer speed, pH level and feed media addition. It is possible to reach 
cell densities higher than shake flasks and stirred tank reactors with the improved oxygen transfer rate and feed.
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Introduction
The current high demand, coupled with therapeutic 
potential of biopharmaceuticals, go hand in hand with 
the demand in improving industrial biotechnological 
processes to produce biopharmaceutical molecules of 
higher quality and quantity. The production of biophar-
maceuticals like therapeutic proteins via fermentation 
processes is not critical as intensive efforts have been 
put into their production. For instance, antibody titers in 
mammalian cell culture has increased drastically over the 
last decades and currently, it is possible to obtain titers 
more than 8  g/L, and protein expression levels higher 
than 15 g/L (Li et al. 2010). However, the mass through-
put in biotechnological production plant is limited due to 
the necessary requirements in the purification of prod-
ucts, in which the costs of production of monoclonal 
antibodies are mostly defined by the costs of the down-
stream processing. The most dominating costs is chro-
matography, filter materials, chemicals and water (Chen 
et  al. 1997; Chin et  al. 2015; Glazyrina et  al. 2010; Hao 
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et al. 2013). Thus, innovative solutions and technologies 
in regard to production times, costs and resources have 
to be developed.
Monoclonal antibodies are attractive tools to develop 
therapeutics due to their multiple applications. They are 
among the most promising compounds on the market 
and one of the pipelines of pharmaceutical biotechnology 
(Carter 2011; Kabir 2002). They can be employed in vivo 
according to their ability to bind specifically to a target 
molecule. In monoclonal antibody purification, affinity 
chromatography has commonly been used with Staphy-
lococcal aureus protein A (SpA) as the ligand. Protein A 
is a type I membrane protein from the bacteria Staphylo-
coccus aureus (Bratkovic et al. 2006; Freiherr von Roman 
et al. 2014; Jungbauer and Hahn 2004; Tsukamoto et al. 
2014), consisting of five domains that have a high affin-
ity for the fragment crystallizable (Fc) region of antibod-
ies (Moks et al. 1986; Pabst et al. 2014; Romagnani et al. 
1982). The SpA molecule consists of a single polypep-
tide chain that folds into helix bundles with a molecular 
weight of approximately 42 kDa. Due to high selectivity 
and good physiochemical stability protein A is a pre-
ferred generic ligand for affinity purification of antibod-
ies and molecules tagged with an antibody Fc region. 
For this reason the molecule have been used for several 
immunological, and purification applications (Asenjo 
and Andrews 2009; Barroso et  al. 2014; Boi et  al. 2009; 
Zamolo et al. 2008; Zhang et al. 2015), therefore there is 
need for high level production of the protein.
The currently used protein production technology is 
based on genetically modified microorganisms such as 
Escherichia coli (E. coli) (Shiloach and Fass 2005; Zhang 
et  al. 2004). It is one of the most widely used host cells 
in recombinant protein production and metabolic engi-
neering, due to its short dividing time, ability to use inex-
pensive substrates and additionally, the genetics of E. coli 
are comparatively simple, well characterized and can eas-
ily be manipulated (Glazyrina et al. 2010; Yee and Blanch 
1992).
The achievement of high cell concentrations and the 
use of recombinant E. coli, it is necessary to develop 
fed-batch strategies and multistage reactor systems for 
fermentation processes that provide high cell mass pro-
ductivity and high stability. The high cell concentrations 
fermentation possess some advantages like, reduced 
reactor volumes, higher volumetric productivities, less 
efforts in up and downstream processing, reduced waste 
water and lower costs of production. Microbial fermenta-
tion can be categorized into three major groups: batch, 
fed-batch, and continuous (Chen et  al. 1997; Glazyrina 
et al. 2012, 2010). Batch processes are suitable for small 
productions and the equipment is relatively simple com-
pared to other processes. However, reaction conditions 
changes with time causing problems in precise fermen-
tation processes, but on the other hand provide high 
production and a better quality product for continu-
ous processes due to constant conditions (Shpigel et  al. 
2000; Yee and Blanch 1992; Cerrone et al. 2014; Ibrahim 
and Steinbuchel 2010). Batch processes are more useful 
for kinetic studies, and require flow control in order to 
maintain constant conditions (Shiloach and Fass 2005). 
The disadvantage of this method is that the cultures can 
be unstable after longer fermentation periods. Fed-batch 
processes primarily focus on increasing the biomass con-
centration and thereby increasing the productivity, while 
minimizing problems encountered in high cell density 
cultivations, since during microbial growth, nutrients, 
gasses, and trace elements (if necessary) are added (Frei-
herr von Roman et al. 2014; Glazyrina et al. 2012, 2010; 
Hoffmann et  al. 2000; Korz et  al. 1995; Krause et  al. 
2010). The volumetric yield of the recombinant product 
depends on both biomass concentrations and the specific 
cellular product yield.
In this study we focused on high-level fed-batch fer-
mentative expression of an engineered SpA B domain 
based ligand in E. coli BL21-DE3 (Novagen, Madison, 
USA), followed by purification and characterization. 
Though SpA has five domains with affinity for the Fc 
region, the molecule shows incapability to simultane-
ously bind five antibody molecules due to steric hin-
drance that might be caused by bound antibodies which 
blocks the access of others to the binding sites. This prob-
lem of steric hindrance encountered with SpA can be 
solved by using an AviPure, a ligand analogue based on 
the native SpA B domain, with a lower molecular weight 
of approximately 14  kDa, containing two repeats of the 
SpA B domain, a histidine tag at the N-terminal for Ni–
NTA based purification and two binding sites (Cysteine–
Histidine) at the C-terminal for the immobilization via 
epoxy groups to the solid support.
Materials and methods
Protein engineering
AviPure with two domain repeats was designed based on 
Staphylococcus aureus M0464 SpA B domain (accession 
number: KT377029) with some modification at the N, 
linker and C-terminal and the codon optimized sequence 
for expression in E. coli BL21 (DE3) was synthesized 
by Eurofingenomics (Erlangen, Germany) (Additional 
file 1: Figure S1). Molecular sub-cloning of AviPure into 
pET28a (+) was performed. Oligonucleotide primers, 
Avi-Fw ACT AGC TAG CGG ATC CCT GGC GGA 
TAA TAA ATT TAA C containing BamHI restriction 
site and Avi-Rv GAA TTC TGA AGC TTC CTT AGT 
GGC AAT GGC AAT G containing HindIII restriction 
site (underlined bases indicate BamHI and HindIII sites, 
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respectively) also synthesized by Eurofingenomics (Erlan-
gen, Germany) were used to extract the AviPure gene, 
while restriction enzymes BamHI-HF and HindIII-HF 
were purchased from New England Biolab (NEB, USA). 
The expression vector pET28a (+) was from Novagen 
(San Diego, CA, USA). AviPure PCR amplification was 
done using the Phusion® High-Fidelity DNA Polymer-
ase (NEB, USA) consisted of 36 cycles of 94 °C for 30 s, 
60  °C for 40  s and 72  °C for 2  min, and followed by a 
final extension step at 72  °C for 5  min, producing PCR 
gene product of about 407 bp. Plasmid pET28a (+) and 
PCR products were purified using NucleoSpin® Plasmid 
extraction and NucleoSpin® Gel and PCR Clean-up kit 
(Macherey–Nagel GmbH and Co. KG, Düren, Germany). 
The pET28a (+) and amplified AviPure gene product 
were individually digested (BamHI-HF and HindIII-HF) 
and ligated to obtain pAV01 with the N-terminal hexa-
histidine tag that facilitate easy purification via Ni–NTA 
resin. The obtained expression vector was initially ampli-
fied in E. coli TOP10 cells and the correctness of the 
sequence was verified by analytical restriction digest and 
DNA sequencing (Eurofins MWG Operon, Ebersberg, 
Germany). The plasmid pAV01 was later isolated and 
subsequently transformed into E. coli BL21(DE3) cells to 
obtain the E. coli BL 21 (DE3):pAV01 for target protein 
expression.
Nucleotide sequence accession numbers
Gene sequences generated in this study were deposited 
in GenBank and the accession numbers are KT377029.
Protein expression
Five different media was analyzed for AviPure produc-
tion: (1) Luria–Bertani medium broth (LB) (10  g/L 
bacto-tryptone, 5 g/L yeast extract, 5 g/L NaCl); (2) Ter-
rific medium broth (TB) (12  g/L tryptone, 24  g/L yeast 
extract, 9.4  g/L K2HPO4, 2.2  g/L  KH2PO4, 4  mL 98  % 
w/v glycerol); (3) M9 minimal medium (M9) (12.8  g/L 
Na2HPO2, 3  g/L KH2PO4, 0.5  g/L NaCl, 2  g/L NH4Cl, 
20 g/L glucose, 0.01 g/L CaCl2, 0.12 g/L MgSO4, 0.002 g/L 
FeCl3); (4) Modified Minimal Medium (MMM) [30  g/L 
glucose, 1.2 g/L MgSO4 × 7H2O, 13.3 g/L KH2PO4, 4 g/L 
(NH4)2HPO4, 1.7  g/L citric acid, 10  mL of trace metals 
solution, 100 µL thiamine HCL (45 mg/mL)]; (5) Riesen-
berg Mineral Medium (RMM) (7.8 g/L KH2PO4, 2.33 g/L 
(NH4)2PO4, 10  g/L glucose, 0.5  g/L citric acid, 1.1  g/L 
MgSO4 × H2O, trace element solution, thiamine HCl.
E. coli BL 21 (DE3):pAV01 cells from a glycerol stock 
were initially plated on LB-agar plate containing appro-
priate antibiotics and incubated overnight at 37  °C, one 
single colony was later inoculated into 2 mL LB medium 
supplemented with appropriate antibiotics and cultured 
overnight at 37 °C with shaking at 225 rpm. The overnight 
culture then centrifuge and re-suspended in appropriate 
media, was transferred into Erlenmeyer flask containing 
1 L cultures of each media and were incubated at 37 °C, 
at 225 rpm. All media were supplemented with 25 mg/L 
final amount of Kanamycin to avoid contaminations. Pro-
tein expression was induced by the addition of 1 mM final 
concentration Isopropyl β-D-1-thiogalactopyranoside 
(IPTG) at OD600 0.5. Samples were taken before and after 
induction and both the supernatant and the pellets were 
analyzed in a 15 % SDS-PAGE.
Mini‑pilot scale fermentation of AviPure
For mini-pilot scale fermentation, TB and MMM were 
used. Initially, overnight cultures supplemented with 
appropriate antibiotics was prepared in 4  mL LB, fur-
ther transferred and cultured to an OD600 of 1.0 in 
500 mL Erlenmeyer flask of either TB or MMM media. 
The culture was later used to inoculate 9.5 L of TB and 
MMM media in a 30 L TV Techfors-S (Infors HT, Swit-
zerland) fermenter previously sterilized at 121  °C for 
20  min and cooled to 37  °C, respectively. During fer-
mentation process some parameters were observed due 
to their importance; the change in OD, pH, aeration, 
antifoam, carbon source, agitation. At first the fermen-
tation was run in batch mode with dissolved oxygen 
level maintained at required saturation (pO2) by using 
filtered air and with stirring speed in cascade mode in 
order to achieve and keep pO2 level constant. The pro-
duction of foam was hindered by using 5  % antifoam 
solution (Sigma Aldrich, Germany) and the cultivation 
temperature was set at 37 °C. During fermentation, the 
pH of the media was maintained at 6.8 using a stand-
ard pH electrode (Mettler Toledo, USA) by the addition 
of phosphoric acid and liquid ammonia and monitored 
using the pH sensor unit. Before switching to fed-batch, 
the dissolved oxygen was used as a guide of the amount 
of feed needed (Yee and Blanch 1992), with the DO-stat 
used to balance the amount of glycerol/glucose needed 
at a time. Calibrated peristaltic pumps were used to 
control the feed rate for feed media (85  % glucose for 
MMM) which was determined by the metabolic rate of 
the culture. During fermentation, sampling of the cul-
ture in the medium was performed and analyzed for 
wet cell weight, and optical density at 600  nm. After 
22  h, feed was reduced and protein expression was 
induced with 1  mM final concentration of IPTG solu-
tion. Cultivation was continued further 3 h till the end 
of cultivation time. E.coli cells pellets were collected by 
centrifugation using the Thermo Scientific Contifuge 
Stratos tabletop centrifuge, having a continuous flow 
rotor at 16,000 rpm, at 4 °C.
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Protein purification
For AviPure purification, 5  g biomass (pellets) from the 
previously mini-pilot scale fermentation was re-sus-
pended in 40 mL sonication/Wash buffer (50 mM Phos-
phate Buffer pH 7.5, 300  mM NaCl, 10  mM Imidazole) 
and 350 µL protease inhibitor cocktail mix. Direct soni-
cation was performed for 45 min using amplitude of 90 % 
and 0.6 cycles; with the beaker containing cell suspen-
sion placed in ice/ice cold water and was continuously 
stirred to keep cool. After sonication, the lysate was cen-
trifuged for 1 h at 16,000  rpm using a Beckman Coulot 
Avanti J-E centrifuge to get rid of cell debris. IMAC was 
used to purify the target protein and a 5  mL Ni–NTA 
column volume was chosen, equilibrated with sonica-
tion/wash buffer before loading. After centrifugation, 
the final 40 mL supernatant was loaded on the column. 
UPC–900 Amersham Biosciences AKTA FPLC system 
was employed for the purification. The elution buffer 
used was the same as the sonication/wash buffer, but 
contained a higher imidazole concentration (250  mM). 
The obtained protein was analyzed by SDS-PAGE follow-
ing the method of Laemmli.
IgG affinity detection of AviPure via Western blot analysis
The affinity of the AviPure for IgG was investigated using 
protein affinity binding. Samples collected during cultiva-
tion (before and after induction) were resolved by a 15 % 
SDS-PAGE gel. Separated proteins were blotted onto 
nitrocellulose membranes (Whatman, Dassel, Germany) 
using a wet electro-blotting apparatus (Bio-Rad, USA). 
To prevent non-specific binding, the free binding sites of 
the membranes were saturated with 5 % fat free dry milk 
powder in TTBS (overnight at 4 °C with gentle agitation). 
Thereafter, the membrane was thoroughly washed five 
times, each for 5 min with 50 mL TTBS. After each incu-
bation, the membrane was washed in the same way. The 
Goat anti-protein A polyclonal antibodies HRP conjugate 
at dilution of 1: 6000 was applied to the membrane, incu-
bated for 1.5 h at room temperature with gentle agitation. 
This was followed by washing and the membranes were 
washed again and the proteins were subsequently visual-
ized with a chemiluminescence kit (ECL) on X-ray film.
Ouchterlony radial immunodiffusion
To perform this method agar media was prepared by 
melting 2  g of agar in 50  mL buffer solution (50  mM 
PO4−, 75 mM NaCl at pH 7.5) and diluting with 50 mL 
water. 450  μL of IgG were added to this solution. Petri 
dishes were used as plates for the test. Several holes were 
made in the solid agar solution to inject fractions and 
standards for comparison. Commercial protein A (Repli-
gen, USA) (0.5 mg/mL) was used as a standard.
Mass spectrometry
The purity and characterization of AviPure eluted from 
SEC was analyzed by mass spectrometry (Bruker Dal-
tonik GmbH) (MALDI-TOF). 2, 5-dihydroxybenzoic acid 
(DHB) was applied as matrix solution and the Bruker 
PepMix Calibration Standard (# 222570, Bruker Dalton-
ics) for the calibration of the instrument. For preparation 
of the matrix on the AnchorChip the DHB matrix layer 
method was used (for details see also AnchorChip Man-
ual and Bruker Daltonics product sheets). The Autoflex II 
software was implemented for the evaluation of samples.
Results
Protein engineering
To design the AviPure ligand, the gene fragment coding 
for the B domains was successfully PCR amplified using 
the primers producing a PCR gene product of about 
407  bp, restricted digested and was in frame ligated 
into pET28a (+) vector to obtain the expression vector 
pAV01. In the final vector plasmid pAV01, the B domain 
sequences were arranged in series, and later transformed 
into E.coli BL21 (DE3) to obtain the engineered E. coli 
BL21 (DE3):pAV01 that was further used in soluble pro-
tein expression.
Mini‑pilot scale fermentation of protein A AviPure
Batch fermentations in baffled flasks (Nalgene) were per-
formed to examine the effects of medium composition 
on cell growth and biomass production in recombinant 
E. coli:pAV01. Initially, high density biomass and protein 
level expression was compared in five different 1 L shaken 
culture media to help determine the most favorable 
media and optimal growth conditions for higher quantity 
protein and biomass production. During shaking culti-
vation, increase in cell density was observed in complex 
media type TB (Table  1), when using the baffled Erlen-
meyer flask type. The total protein concentration from 
the collected 1 mL cell pellets obtained from the overall 
cultures was determined using the bicinchoninic acid 
(BCA) assay from Pierce (Rockford, USA) and protein 
expression was further analyzed using 15 % SDS-PAGE. 
From Table 1, the results show high total protein and bio-
mass production in LB and TB, with TB producing even 
higher, while less biomass production was observed in 
mineral salt media MMM, M9 and RMM. Higher protein 
content (per gram of cell mass) was observed in complex 
media containing rich nutrients like yeast extracts than 
in synthetic media. However, the total protein/biomass 
ratio for all the media was nearly the same.
Based on the shaking culture results, TB, a complex 
medium and MMM, a synthetic medium (Table  1) 
were used in mini-pilot scale fermentation. During 
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fermentation, batch culture, then followed by fed batch 
techniques were used to obtain high cell densities. Bio-
mass production was monitored during cultivation 
at OD600, and from Fig.  1 it can be observed that the 
feed rate increased exponentially to maintain a specific 
growth rate at 37  °C. Feed media (glucose) was added 
to introduce a carbon source and for the purpose of 
achieving higher cell density. The feed rate adjust-
ments were done according to observations in the pre-
vious shake flask studies. After 22 h of cultivation, feed 
was reduced and culture was induced with 1 mM IPTG 
final concentration for the induction of the T7 pro-
moter-mediated gene expression and for the produc-
tion of AviPure. From Fig. 1, the relationship between 
growth rates in time and change in biomass can easily 
be noticed as the exponential growth phase between 
12 and 22  h is the most remarkable. During fermen-
tation, it was also observed that as the bacterial cul-
ture grows pO2 saturation decreases; this was due to 
the increase in O2 uptake by the culture. To maintain 
higher pO2 concentration, the stirrer speed was main-
tained in cascade mode, with the continuously aera-
tion using filter air and by adding feed. Any change in 
pO2 level combined with a pH change triggers the pO2 
controller. During fermentation, a total of 4800  g of 
glucose was used, representing 5.6 L injected into the 
fermenter. The final volume after fermentation was 
about 15  L. After 25  h of fermentation, product yield 
of biomass from the media was about 1200 and 2410 g 
(wet weight) for TB and MMM, respectively. The dry 
weight obtained from MMM fermentation was about 
52 g/L.
Table 1 Comparison of different media on total protein and biomass production by E. coli BL21 (DE3)/pAV01
Media Total proteins (g/L) Biomass (g/L) Total protein/biomass ratio
LB 2.10 ± 0.12 10.22 ± 0.27 0.21
Terrific broth 3.02 ± 0.25 14.60 ± 0.95 0.21
M9 minimal medium 1.40 ± 0.11 7.45 ± 0.50 0.19
Modified minimal medium 1.63 ± 0.11 8.25 ± 0.38 0.20
Riesenberg mineral medium 1.57 ± 0.07 7.58 ± 0.33 0.21
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Fig. 1 Optical density (OD) and biomass change in time during fermentation. X‑axis shows time in hours. Y‑axis at the left side shows stirrer speed 
(RPM) and dissolved oxygen concentration (%) and Y‑axis at the right side shows biomass accumulation and feed over the time. Accretion of bio‑
mass is related with increase of OD600
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During fermentation process they are some charac-
teristic phases which affect the procedure. Therefore, to 
improve the efficiency and yield in fermentation, manip-
ulation of each phase has an effect on the growth of E. 
coli were observed. In fermentation, change in optical 
density is related to the growth rate of bacterial cells and 
the results in Fig.  1, clearly shows the relation between 
E. coli growth rate and change of biomass in which the 
exponential growth phase is the most remarkable and it 
shows that the inoculation of the culture medium with 
resultant growth rate at a specific rate (μ) increasing from 
near zero to maximum (μmax). The results show that the 
exponential phase is characterized by the exponential 
growth rate at μ = μmax and from the extrapolated results 
(Fig.  2a, b) shows that the specific growth rate for the 
exponential phase in our study was around 0.3. Addition-
ally, the cell concentration (cx in g/L) during fermentation 
at a given point was calculated by using OD = 0.54 × bio-
mass, equalize to OD/cx  =  0.54, previously obtained 
from the trendline in Fig. 2a. In(cx) = µmax × t − a was 
further extracted from the ln(cx) against the time plot. 
By using this information, we were able to calculate the 
starting cell concentration cx,0 = e−a (g/L). Maximum 
growth rate during the exponential phase was found to 
be μmax = 0.45 (Fig. 2b) and the initial cell concentration 
is 0.31 (g/L) during fermentation.
Protein purification and SDS‑PAGE gel
Before chromatographic separation, the sonically lysed 
cells were centrifuged to remove the insoluble particles 
and the 40 mL of supernatant was loaded on the Ni–NTA 
column and the performance of the complete purification 
process can be seen in Fig. 3a. From the figure, three dis-
tinctive stages can clearly be identified. The AviPure elu-
tion fractions were pooled, collected and dialyzed. The 
concentrations of purified protein samples were deter-
mined using a Nanodrop 2000c from Thermo Scientific 
(Wilmington, DE, USA) with the micro volume pedestal 
and measurement at a wave-length of 280 nm. A total of 
1.65 mg/g of protein per gram cell biomass was obtained 
and the product had a purity of over 90  % as was fur-
ther confirmed by 15 % SDS-PAGE with coomassie blue 
staining (Fig.  3b). The process yield of more than 90  % 
was achieved, though some bands (impurities) of higher 
molecular weight than AviPure were visible. Due to this, 
a second purification step using size exclusion chroma-
tography (SEC) (data not shown) was carried out with the 
aim of getting rid of the impurities.
Ouchterlony radial immunodiffusion
Ouchterlony radial immunodiffusion analysis assay 
(Fig.  4a) was performed to check AviPure (A1 and A2) 
binding activity with immunoglobulin (Octagam, Aus-
tralia), while commercial protein A designated as R 
(Repligen, Waltham, MA, USA) was applied as control 
standard of protein concentration ranging from 5 to 
0.1 mg/mL and each analysis was numbered from 1 to 4.
After 24 h of incubation, faint white precipitation rings 
could be seen on the gels with the naked eye. To amplify 
these rings, the gel was then stained with Coommas-
sie Blue and the significant dark ring of precipitation is 
clearly observed, except in well X where BSA was applied.
IgG affinity detection of AviPure via Western blot analysis
The validity of the purified AviPure was also confirmed 
by western blot using goat anti-protein A polyclonal anti-
bodies HRP conjugate. The western blot yielded a major 
band that corresponded to the right molecular weight of 
the AviPure (Fig. 4b, lanes 3 and 4). No other additional 
bands were detected by the method, indicating that a 
pure protein was obtained and no proteolysis occurred 
during purification and storage.
Fig. 2 a Relationship of OD600 to biomass production in E. coli. Linear 
increase of growth rate is shown in the figure by relating biomass and 
OD600. b Maximum growth rate calculated by plotting Incx against 
time
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Mass spectrometry
The purified AviPure from SEC showed a single peak in 
the elution profile fraction, showing that the purity of 
protein was almost 100 % (Data not shown). In order to 
investigate SEC results, further analysis of the purified 
AviPure were conducted by MS MALDI-TOF (Fig.  5) 
which gave one prominent peak, presenting the Avi-
Pure of 14.2 kDa, slightly lower than the mass predicted 
from the DNA sequence of AviPure (15 kDa), but within 
the error limit of the technique. This peak proves the 
molecular weight of the purified AviPure, while peaks 
below 10,000  m/z (mass/charge) represent background 
noise from the instrument.
Discussion
Staphylococcus aureus protein A is a highly stable cell 
surface receptor consists of five domains that have high 
affinity for the Fc region of IgG and has widely been used 
mainly in monoclonal antibody purification. In this study, 
to design the AviPure ligand, we focused on the B domain 
Fig. 3 a A chromatographic runs of AviPure purification with 5 mL Ni–NTA column, (1) load, (2) wash, (3) elution fraction. b Coomassie Blue stained 
15 % SDS‑PAGE gel from different sample fractions, Lane M represent pre‑stained protein marker, Lane 1 induced pellets from culture, Lane 2 super‑
natant after sonication and centrifugation, Lane 3 flow through, Lane 4 Wash, Lane 5 eluted sample before dialysis, Lane 6 eluted sample after dialysis
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of SpA, the region having a higher affinity for IgG Fc 
region (Watanabe et al. 2013) and we were able to dem-
onstrates that the protein can be prepared in high density 
fed batch fermentation.
During media testing in baffled flasks, it was found 
that complex media (LB and TB) produced high biomass. 
In fermentation, media composition is one of the most 
important parameter that must carefully be considered as 
cell growth and recombinant product yield depend on it 
(Shiloach and Fass 2005; Shpigel et al. 2000; Zhang et al. 
2004). The cultivation media composition ranges in three 
major groups: complex, semi complex, and defined. A 
complex medium contains nutrients which are not well 
defined chemically e.g., yeast extract, tryptone, peptone, 
casamino acids, while defined medium consists of chemi-
cals which are chemically defined. Semi defined media is 
a combination of both complex and defined media nutri-
ents (Panda 2003; Panula-Perala et  al. 2008; Schiraldi 
et al. 2001).
The reason behind high biomass production observed in 
our batch study when using TB in baffled flasks could have 
been due to the presence of easy digested yeast extract and 
tryptone which contains wider varieties of peptides and 
trace elements, and also due to the glycerol in TB con-
taining a rich carbon source (Schmidt et al. 2005; Eriksen 
2008; Sun et  al. 2007). On the other hand, fermentation 
parameters such as specific growth rate could be easily 
controlled to get a high cell density in the synthetic (min-
eral) media if carbon rich sources are utilized as fed batch, 
as can be seen in our results. When mineral salt media is 
prepared and appropriately supplemented with necessary 
ingredients, added in the right order and in exact amounts 
after special sterilization treatments a higher biomass yield 
production is possible (Freiherr von Roman et  al. 2014; 
Korz et al. 1995; Krause et al. 2010).
During fermentation the pH–stat feeding strategy 
was used to deal with the issue of glycerol and glucose 
oscillations based on direct coupling of carbon source 
consumption and also for the maintenance of related 
export and import of proton and ammonium ion by the 
Fig. 4 a Ouchterlony radial immunodiffusion showing cross‑
reactivity of IgG with commercial SpA and purified AviPure. Upper 
Center well (X) contain BSA. Upper row wells (R1–R5) contain differ‑
ent concentration of commercial SpA (concentration 5, 1, 0.5 and 
0.1 mg/mL), while middle (A1:1–4) and lower rows (A2:1–4) contain 
concentration (5, 1, 0.5 and 0.1 mg/mL) of purified AviPure. b Western 
blot analysis of of protein As. Western blot was carried out with Goat 
anti‑protein A polyclonal antibodies HPR conjugate. Lanes 1 and 2; 
Commercial SpA, Lanes 3 and 4 AviPure eluted from SEC
Fig. 5 Identification of AviPure expressed in E. coli by MALDI‑TOF. 
Purified AviPure from size‑exclusion chromatography was used for 
the analyses
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cell during growth. While pH drops by export of H+ and 
import of NH4+ from the cells to the media by consum-
ing a carbon source, pH increases by import of H+ and 
export of NH4+ from the cells when the carbon source is 
exhausted. Although glucose has been used for pH–stat 
feeding in many fermentation processes, in this study, 
glycerol and glucose were preferred for high density cul-
ture of E. coli by pH–stat (Shimizu 2013; García-Arrazola 
et al. 2005).
Medium composition and growth strategies play the 
most important role in optimizing high density-cell fer-
mentation processes, as product quality insurance and 
yield of product are the key issues for large scale fermen-
tations. Process optimization and scale up are aimed to 
maintain optimum and homogeneous reaction condi-
tions and consequently to minimize stress exposure and 
enhance metabolic accuracy.
Furthermore, we focused on protein purification and 
characterization. From the results we can clearly see that 
the protein was expressed, purified and via western blot, 
Ouchterlony immunodiffusion assay, the protein main-
tained its affinity for immunoglobulins.
In this study, high level fed batch fermentation 
was achieved when using MMM. Several fermen-
tation parameters such as culture growth media, 
growth conditions and chemical concentrations, pO2 
level, stirrer speed, pH level and feed media addition 
were optimized for high density biomass produc-
tion. The conditions made it possible to culture cells 
up to 172 g/L wet biomass, (52 g/L dry mass) in 25 h, 
though Nakano et  al. were able to reach cell concen-
trations of up to 190 and 180 g/L dry cell weight after 
30  h fermentation in glucose and glycerol medium 
(Nakano et al. 1997), respectively. From the reference, 
the result shows that it possible to obtain higher bio-
mass if continuous feed of carbon source and oxygen 
available. The final yield of purification process was 
1.6 milligrams of AviPure per gram biomass a remark-
able result when compared to current literature was 
achieved. Activity and molecular structures were 
checked with suitable methods as described before. 
Results of the characterization experiment showed 
that after purification steps only a single monomer 
with a size of 14.2 kDa was present.
The next step is to further characterize and determine 
the potential application of AviPure for the capture of 
Immunoglobulin.
Additional file
Additional file 1: Figure S1. DNA nucleotide sequence for Avipure 
(underlined). Start codons is indicated in bold. Stop codon is highlighted 
in red.
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